Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Selegiline Hydrochloride
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : E-Group ICT Software Informatikai Zrt.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Selegiline is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Prostatic Neoplasms, Castration-Resistant.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 14, 2020
Lead Product(s) : Selegiline Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : E-Group ICT Software Informatikai Zrt.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Selegiline Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
Details : Selegiline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Borderline Personality Disorder.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 31, 2013
Lead Product(s) : Selegiline Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable